Sattva Sukun Lifecare Limited carries a market capitalization of 287.70M, placing it among publicly traded companies globally. Its enterprise value stands at 232.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 287.70M |
| Enterprise Value | 232.96M |
Sattva Sukun Lifecare Limited trades at a trailing price-to-earnings ratio of 14.18.
| PE Ratio | 14.18 |
| PS Ratio | 0.94 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Sattva Sukun Lifecare Limited trades at an EV/EBITDA multiple of 13.76 and an EV/FCF ratio of 677.54. The EV/Sales ratio of 0.94 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.76 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.94 |
| EV / EBITDA | 13.76 |
| EV / EBIT | 13.76 |
| EV / FCF | 677.54 |
Sattva Sukun Lifecare Limited maintains a current ratio of 7.87, meaning it holds 7.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.72, indicating elevated leverage, while an interest coverage ratio of 39.92 demonstrates strong ability to service its debt obligations.
| Current Ratio | 7.87 |
| Quick Ratio | 0.08 |
| Debt / Equity | 3.72 |
| Debt / EBITDA | N/A |
| Interest Coverage | 39.92 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 23.02 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Sattva Sukun Lifecare Limited has paid 3.69M in income taxes, reflecting an effective tax rate of 18.91.
| Income Tax | 3.69M |
| Effective Tax Rate | 18.91 |
Sattva Sukun Lifecare Limited's stock has declined approximately -32.43243% over the past 52 weeks. The 50-day moving average sits at 0.72, while the 200-day moving average is 0.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -32.43243% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.75 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Sattva Sukun Lifecare Limited generated 247.98M in revenue and converted that into 16.43M in net income, yielding earnings per share of 0.05. EBITDA reached 16.93M, while operating income came in at 16.93M.
| Revenue | 247.98M |
| Gross Profit | 49.33M |
| Operating Income | 16.93M |
| Pretax Income | 19.50M |
| Net Income | 16.43M |
| EBITDA | 16.93M |
| EBIT | 16.93M |
| Earnings Per Share (EPS) | 0.05 |
Sattva Sukun Lifecare Limited operates with a gross margin of 19.89, reflecting its pricing power and cost economics. The operating margin of 6.83 and net profit margin of 6.63 provide insight into operational efficiency.
| Gross Margin | 19.89 |
| Operating Margin | 6.83 |
| Pretax Margin | 7.86 |
| Profit Margin | 6.63 |
| EBITDA Margin | 6.83 |
Sattva Sukun Lifecare Limited's most recent stock split took place on October 25, 2024 with a 1:5 split ratio.
| Last Split Date | 10/25/2024 |
| Split Ratio | 1:5 |
Sattva Sukun Lifecare Limited posts an Altman Z-Score of 2.24, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.24 |